Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organ-on-a-Chip–Guided Dexamethasone for ARDS
ChiCTR2500110842Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in acute respiratory distress syndrome (ARDS) (4 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Proportion of patients achieving a reduction >2 points in the Lung Injury Score (LIS) at Day 5. Started Oct 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2500110842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110842.